GlassScriptPhysician profile
Cindy Sullins
NPI 1336507250
$2,885.30
in general payments reported to CMS, 2019-2025
13 companies · $837 in 2025
The $837 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $384 · 2022: $239 · 2023: $346 · 2024: $1,079 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,243 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,242.57 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,242.05 | 2022-2025 | Biktarvy, Yeztugo |
| Viiv Healthcare Company | $933.99 | 2022-2025 | Apretude, Cabenuva, Dovato |
| Merck Sharp & Dohme LLC | $325.61 | 2022-2025 | Pifeltro, Delstrigo |
| Daiichi Sankyo INC. | $113.87 | 2021 | |
| Mallinckrodt Hospital Products INC. | $61.54 | 2021 | |
| Akebia Therapeutics INC | $36.94 | 2021 | |
| Welch Allyn | $34.73 | 2021 | |
| Vifor Pharma, INC. | $33.01 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $26.94 | 2021 | |
| Aurinia Pharma U.S., INC. | $23.98 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.82 | 2021 | |
| Abbvie INC. | $17.71 | 2021 | |
| Opko Pharmaceuticals, LLC | $16.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Sullins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.